Advanced search
Publication Cover
Leukemia & Lymphoma Volume 44, 2003 - Issue 5
Submit an article Journal homepage
78
Views
8
CrossRef citations to date
0
Altmetric
Research Article

ACOD, a Modified CHOP Regimen for Elderly Patients with Aggressive Non-Hodgkin's Lymphoma

P. Santoro Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
G. Martinelli Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
P.F. Ferrucci Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
W. Mingrone Oncology Institute of Southern Switzerland, Ospedale San Giovanni CH-6500 Bellinzona, Switzerland
,
E. Cocorocchio Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
A. Conconi Oncology Institute of Southern Switzerland, Ospedale San Giovanni CH-6500 Bellinzona, Switzerland
,
F.A. Peccatori Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
K. De Luzio Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
C. Mazzetta Division of Hematoncology, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy
,
E. Zucca Oncology Institute of Southern Switzerland, Ospedale San Giovanni CH-6500 Bellinzona, Switzerland
&
F. Cavalli Oncology Institute of Southern Switzerland, Ospedale San Giovanni CH-6500 Bellinzona, Switzerland
 show all
Pages 801-806 | Published online: 01 Jul 2009

  • Coiffier, B., Biron, P., Bastion, Y., et al. (1996) "Elderly lymphoma patients have a long survival if treated with curative intent. A study from the GELA on 453 patients older than 69 years", Proc. Am. Soc. Clin. Oncol. 15, 417. Abstract 1279.
  • Dixon, D.O., Neilan, B., Jones, S.E., et al (1986) "Effect of age on therapeutic outcome in advanced diffuse histocytic lymphoma: the Southwest Oncology Group experience", J. Clin. Oncol. 4. 295-305.
  • Kwak, I.W., Halpern, J., Olsben, R.A., et al. (1990) "Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: a tree-structured survival analysis", J. Clin. Oncol. 8, 963-977.
  • LePage, E., Gisselbrecht, C., Haioun, C., et al. (1993) "Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol", Ann. Oncol. 4,651-656.
  • Solal-Celigny, P., Chastang, C., Herrera, A., et al. (1987) "Age as the main prognostic factor in adult aggressive NHL", Am. J. Med, 83, 1075-1079.
  • Vose, J.M., Armitage. J.O., Weisemburger, D.D., et al. (1988) "The importance of age in survival of patients treated with chemotherapy for aggressive NHL", J. Clin. Oncol. 6. 1838 1844.
  • Shipp, M.A., Harrington, D.P., Anderson. J.R., et al. (1993) "A predictive model for aggressive NHL: the International NHL prognostic factors project", N. Engl. J. Med. 329, 987-994.
  • Grogan, L., Corbally, N., Dervan, P.A., Byrne, A. and Carney, D.N. (1994) "Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimens", Ann. Oncol. 5(Suppl. 2), 47-51.
  • Tirelli, U., Errante, D., Van Glabbeke, M., et al. (1998) "CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group", J. Clin. Oncol 16, 27-34.
  • Meyer, R.M., Browman, G.P., Samosh, M.L., et al. (1995) "Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma", J. Clin. Oncol. 13, 2386-2393.
  • Sonneveld, P., de Ridder, M., van der Lelie, H., et al. (1995) "Comparison of adriamycin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy", J. Clin. Oncol. 13. 2530-2539.
  • Gomez, H., Mas, L., Casanova, L., et al. (1998) "Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte macrophage colony-stimulating factor: identification of two age subgroups with differing bematological toxicity", J. Clin. Oncol. 16, 2352-2358.
  • Martelli, M., Guglielmi, S., et al (1993) "P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma", J. Clin. Oncol. 11, 2362-2369.
  • Bertini, M., Freilone, R., Vitolo. L., et al. (1996) "The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive muitidrug regimen", Leuk. Lymphoma 22, 483-493.
  • Bessell, E.M., Coulis, A., Fletcher. J., et al. (1994) "Non-Hodgkin's lymphoma in elderly patients: a phase Il study of MCOP chemotherapy in patients aged 70 years or over with intermediate or high-grade histology", Eur. J. Cancer 30A, 1337-1341.
  • Tirelli, U., Zagonel, V., Errante, D., et al. (1992) "A prospective study of a new combination chemotherapy regiinen in patients older than 70 years with unfavorablenon-Hodgkin's lymphoma", J. Clin. Oncol. 10, 228-236.
  • Jones, S.E., Grozea, P.N. and Metz. E.N. (1979) "Superiority of adriamycin-containing combination therapy in the treatment of diffuse lymphoma. A Southwest Oncology Group Study", Cancer 43, 417-425.
  • Bajetta, E., Valagussa, P., Bonadonna, G., et al. (1988) "Combined modality treatment for stage I Il LNH: CVP versus BACOP chemotherapy", Int. J. Radiol. Oncol. Biol. Phys. 1, 3-12.
  • Millar, T.P. and Jones, S.F., (1983) "Initial chemotherapy for clinically localized lymphomas of unfavorable histology", Blood 52, 413-418.
  • Cheeson, B.D., et al (1999) "Report of an International Workshop to standardize response criteria for non-Hodgkin's lymphoma", J. Clin. Oncol. 17, 1244-1253.
  • National Cancer Institute's (NCI) Common Toxicity Criteria. Version 2.0. June I 1999. www http: www.ctep-dev.cancer.gov/ reporting/ctc.html.
  • Hryniuk, W.M. (1988) 'The importance of dose intensity in the outcome of chemotherapy", In: Hellman. S., De Vita, V. and Rosemberg, S., eds. Important Advances in Oncology (Philadelphia 1988) (Philadelphia, JB, Lippincott). pp. 121-141.
  • Hosmer, D.W. and Lemeshow, S. (2002) Applied Logistic Regression. Edit (Wiley Interscience, New York, 1989).
  • S-PLUS 2000 Professional Release 2 Copyright (c) 1988-1989 MathSoft. Inc.
  • Fisher, R.I., Gaynor. E.R., Dahlberg, S., et al. (1993) "Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced NHL", N. Engl. J. Med. 328, 1002-1006.
  • Armitage, J.O. and Potter, J.F. (1984) "Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly. Increased complications of advancing age", J. Am. Geriatr. Soc. 32, 269-273.
  • Radford, J.A., Whelan, J.S., Rohatiner, A.Z., et al. (1994) "Weekly VAPEC-B chemotherapy for high grade NHL: results of treatment in 184 patients", Ann. Oncol. 5/2. 47-51.
  • Coiffier, B., Lepage, E., Briere, J., Herbrecht, R., Tilly, H., Bouabdallah, R., Morel, P., Van Den Neste, E., Salles, G., Gaulard, P., Reyes, F., Lederlin, P. and Gisselbrecht, C. (2002) "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma", N. Engl. J. Med. 346(4). 235-242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.